Think 24/7 Web Search

Search results

  1. Results from the Think 24/7 Content Network
  2. MDAI - Wikipedia

    en.wikipedia.org/wiki/MDAI

    MDAI ( 5,6-methylenedioxy-2-aminoindane) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non- neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces entactogen effects in humans.

  3. 2-Aminoindane - Wikipedia

    en.wikipedia.org/wiki/2-Aminoindane

    2-Aminoindane ( 2-AI) is a research chemical with applications in neurologic disorders and psychotherapy that has also been sold as a designer drug. [1] It acts as a selective substrate for NET and DAT. [2] [3]

  4. 3,4-Methylenedioxyamphetamine - Wikipedia

    en.wikipedia.org/wiki/3,4-Methylenedioxyamphetamine

    3,4-Methylenedioxyamphetamine. 3,4-Methylenedioxyamphetamine (also known as MDA and sass) is an empathogen-entactogen, psychostimulant, and psychedelic drug of the amphetamine family that is encountered mainly as a recreational drug. In its pharmacology, MDA is a serotonin–norepinephrine–dopamine releasing agent (SNDRA).

  5. List of designer drugs - Wikipedia

    en.wikipedia.org/wiki/List_of_designer_drugs

    This class of drugs are mimics of serotonin that activate 5-HT receptor subtypes that release norepinephrine and dopamine. 2C-B-BZP. 3-Chlorophenylpiperazine, meta-Chlorophenylpiperazine, mCPP. 4-Fluorophenylpiperazine, para-Fluorophenylpiperazine, pFPP, 4-FPP, Fluoperazine, Flipiperazine.

  6. MEAI - Wikipedia

    en.wikipedia.org/wiki/MEAI

    MEAI ( 5-methoxy-2-aminoindane or 5-MeO-AI or Chaperon) belongs to the indane family of molecules. Its molecular structure was first mentioned implicitly in a markush structure schema appearing in a patent from 1998. [ 1] It was later explicitly and pharmacologically described in a peer reviewed paper in 2017 by David Nutt and Ezekiel Golan et ...

  7. 5-IAI - Wikipedia

    en.wikipedia.org/wiki/5-IAI

    5-Iodo-2-aminoindane ( 5-IAI) is a drug which acts as a releasing agent of serotonin, norepinephrine, and dopamine. [ 2] It was developed in the 1990s by a team led by David E. Nichols at Purdue University. [ 3] 5-IAI fully substitutes for MDMA in rodents and is a putative entactogen in humans. [ 3] Unlike related aminoindane derivatives like ...

  8. MDMAI - Wikipedia

    en.wikipedia.org/wiki/MDMAI

    MDMAI. 5,6-Methylenedioxy-N-methyl-2-aminoindane ( MDMAI ), is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non- neurotoxic and highly selective serotonin releasing agent (SSRA) in animals and a putative entactogen in humans. [1]

  9. Empathogen - Wikipedia

    en.wikipedia.org/wiki/Empathogen

    e. Empathogens or entactogens are a class of psychoactive drugs that induce the production of experiences of emotional communion, oneness, relatedness, emotional openness—that is, empathy or sympathy—as particularly observed and reported for experiences with 3,4-methylenedioxymethamphetamine ( MDMA ). [1] This class of drug is distinguished ...